Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.

Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, Chen Y, Li H, Shi G, Cang H, Sun Y, Wang J, Wang W, Gao F, Yi J.

J Biol Chem. 2010 Apr 23;285(17):12906-15. doi: 10.1074/jbc.M109.071431. Epub 2010 Feb 24.

2.

SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.

Wang M, Sang J, Ren Y, Liu K, Liu X, Zhang J, Wang H, Wang J, Orian A, Yang J, Yi J.

Protein Cell. 2016 Jan;7(1):63-77. doi: 10.1007/s13238-015-0216-7. Epub 2015 Oct 28.

3.

Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.

Hirano S, Tadano M, Kobayashi Y, Udagawa O, Kato A.

Toxicol Appl Pharmacol. 2015 Sep 15;287(3):191-201. doi: 10.1016/j.taap.2015.05.018. Epub 2015 Jun 3.

PMID:
26049103
4.

Small Ubiquitin-like Modifier Alters IFN Response.

Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK.

J Immunol. 2015 Sep 1;195(5):2312-24. doi: 10.4049/jimmunol.1500035. Epub 2015 Jul 29.

5.

The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.

Hattersley N, Shen L, Jaffray EG, Hay RT.

Mol Biol Cell. 2011 Jan 1;22(1):78-90. doi: 10.1091/mbc.E10-06-0504. Epub 2010 Dec 9.

6.

In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.

Saitoh N, Uchimura Y, Tachibana T, Sugahara S, Saitoh H, Nakao M.

Exp Cell Res. 2006 May 1;312(8):1418-30.

PMID:
16688858
7.

The biphasic redox sensing of SENP3 accounts for the HIF-1 transcriptional activity shift by oxidative stress.

Wang Y, Yang J, Yang K, Cang H, Huang XZ, Li H, Yi J.

Acta Pharmacol Sin. 2012 Jul;33(7):953-63. doi: 10.1038/aps.2012.40. Epub 2012 Jun 11.

8.

SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.

Fasci D, Anania VG, Lill JR, Salvesen GS.

Sci Signal. 2015 Jun 9;8(380):ra56. doi: 10.1126/scisignal.aaa3929.

9.

Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.

Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, Niwa-Kawakita M, Faklaris O, Setterblad N, de Thé H, Lallemand-Breitenbach V.

J Cell Biol. 2014 Mar 17;204(6):931-45. doi: 10.1083/jcb.201305148.

10.

SUMOylation promotes PML degradation during encephalomyocarditis virus infection.

El McHichi B, Regad T, Maroui MA, Rodriguez MS, Aminev A, Gerbaud S, Escriou N, Dianoux L, Chelbi-Alix MK.

J Virol. 2010 Nov;84(22):11634-45. doi: 10.1128/JVI.01321-10. Epub 2010 Sep 8.

11.

SUSP1 antagonizes formation of highly SUMO2/3-conjugated species.

Mukhopadhyay D, Ayaydin F, Kolli N, Tan SH, Anan T, Kametaka A, Azuma Y, Wilkinson KD, Dasso M.

J Cell Biol. 2006 Sep 25;174(7):939-49.

12.

Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.

Gao C, Ho CC, Reineke E, Lam M, Cheng X, Stanya KJ, Liu Y, Chakraborty S, Shih HM, Kao HY.

Mol Cell Biol. 2008 Sep;28(18):5658-67. doi: 10.1128/MCB.00874-08. Epub 2008 Jul 14.

13.

Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.

Evdokimov E, Sharma P, Lockett SJ, Lualdi M, Kuehn MR.

J Cell Sci. 2008 Dec 15;121(Pt 24):4106-13. doi: 10.1242/jcs.038570. Epub 2008 Nov 25.

14.

Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death.

Guan D, Lim JH, Peng L, Liu Y, Lam M, Seto E, Kao HY.

Cell Death Dis. 2014 Jul 17;5:e1340. doi: 10.1038/cddis.2014.185.

15.

Moloney murine leukemia virus integrase and reverse transcriptase interact with PML proteins.

Okino Y, Inayoshi Y, Kojima Y, Kidani S, Kaneoka H, Honkawa A, Higuchi H, Nishijima K, Miyake K, Iijima S.

J Biochem. 2012 Aug;152(2):161-9. doi: 10.1093/jb/mvs063. Epub 2012 Jun 7.

PMID:
22685230
16.

RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.

Klein UR, Haindl M, Nigg EA, Muller S.

Mol Biol Cell. 2009 Jan;20(1):410-8. doi: 10.1091/mbc.E08-05-0511. Epub 2008 Oct 22.

17.

The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

Rabellino A, Carter B, Konstantinidou G, Wu SY, Rimessi A, Byers LA, Heymach JV, Girard L, Chiang CM, Teruya-Feldstein J, Scaglioni PP.

Cancer Res. 2012 May 1;72(9):2275-84. doi: 10.1158/0008-5472.CAN-11-3159. Epub 2012 Mar 9.

18.

SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

Cao X, Clavijo C, Li X, Lin HH, Chen Y, Shih HM, Ann DK.

Mol Cancer Ther. 2008 Apr;7(4):923-34. doi: 10.1158/1535-7163.MCT-07-0540.

19.

Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.

Percherancier Y, Germain-Desprez D, Galisson F, Mascle XH, Dianoux L, Estephan P, Chelbi-Alix MK, Aubry M.

J Biol Chem. 2009 Jun 12;284(24):16595-608. doi: 10.1074/jbc.M109.006387. Epub 2009 Apr 20.

20.

Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments.

Scherer M, Reuter N, Wagenknecht N, Otto V, Sticht H, Stamminger T.

J Gen Virol. 2013 Jun;94(Pt 6):1373-84. doi: 10.1099/vir.0.051078-0. Epub 2013 Feb 13.

PMID:
23407422

Supplemental Content

Support Center